引用本文:弋文娟,陈煜岊,米思倩,蒋燕明.诺舒子宫内膜去除术与宫腔镜下子宫内膜电切术治疗异常子宫出血的疗效比较[J].中国临床新医学,2019,12(1):43-46.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 309次   下载 168 本文二维码信息
码上扫一扫!
分享到: 微信 更多
诺舒子宫内膜去除术与宫腔镜下子宫内膜电切术治疗异常子宫出血的疗效比较
弋文娟,陈煜岊,米思倩,蒋燕明
545000 广西,柳州市人民医院妇科(弋文娟,陈煜岊);530021 南宁,广西壮族自治区人民医院妇科(米思倩,蒋燕明)
摘要:
[摘要] 目的 比较诺舒子宫内膜去除术与宫腔镜下子宫内膜电切术治疗异常子宫出血(AUB)的有效性和安全性。方法 选取2015-01~2017-01药物治疗无效的AUB患者60例,随机分为研究组和对照组各30例。研究组采用诺舒子宫内膜去除术治疗。对照组采用宫腔镜下子宫内膜电切术治疗。分别于术后1、3、6、12个月随访,比较两组的疗效及术后并发症发生率。结果 两组术后月经量均明显减少或闭经,有效率和闭经率差异无统计学意义(P>0.05)。研究组手术时间明显短于对照组(P<0.05),术中出血量少于对照组(P<0.05)。对于术中及术后并发症的发生情况,研究组均优于对照组,但只有电解质紊乱和术后1个月、3个月的腹痛发生情况差异有统计学意义(P<0.05)。结论 在治疗AUB中,诺舒子宫内膜去除术和传统的宫腔镜下子宫内膜电切术均有较好的疗效,但诺舒子宫内膜去除术的安全性优于子宫内膜电切术。
关键词:  诺舒  子宫内膜电切术  异常子宫出血  有效性  安全性
DOI:10.3969/j.issn.1674-3806.2019.01.11
分类号:R 711.52
基金项目:柳州市科技局立项资助项目(编号:2015J030520)
Comparison of the clinical effects between NovaSure endometrial ablation and transcervical resection of endometrium in treatment of abnormal uterine bleeding
YI Wen-juan, CHEN Yu-jie, MI Si-qian, et al.
Department of Gynecology, Liuzhou General Hospital, Guangxi 545000, China
Abstract:
[Abstract] Objective To compare the effectivness and safety between NovaSure endometrial ablation and transcervical resection of endometrium(TRCE) in treatment of abnormal uterine bleeding(AUB). Methods Sixty AUB patients whose previous medications were ineffective were selected from January 2015 to January 2017, and were randomly divided into study group(n=30) and control group(n=30). The study group was treated with NovaSure, and the control group was treated with TRCE. All the patients were followed up respectively at 1, 3, 6, and 12 months after operation to determine their response to the treatment and the incidence of complications. Results The menstrual blood volume was significantly reduced in all the patients after operation, but there were no significant differences in effective rate and amenorrhea rate between the two groups(P>0.05). The operation time of the study group was significantly shorter than that of the control group(P<0.05). The intraoperative blood loss of the study group was significantly less than that of the control group(P<0.05). The intraoperative and postoperative complications of the study group were less than those of the control group, but there were only significant differences in electrolyte disturbance and abdominal pain 1 and 3 months after operation between the two group(P<0.05). Conclusion Both NovaSure and TRCE are effective in treatment of AUB, but NovaSure treatment may be safer.
Key words:  NovaSure  Transcervical resection of endometrium(TRCE)  Abnormal uterine bleeding(AUB)  Effectiveness  Safety